Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
4 clinical trials · Condition
◉ Watch Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET) (NCT07243938) | Tao Zhang | 2026-01-15 |
| Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer (NCT07429318) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-01-01 |
| A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06829797) | Shandong Provincial Hospital | 2025-03-11 |
| Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06766578) | Shandong Provincial Hospital | 2024-12-30 |
Track Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.